{"product_id":"living-legends-in-psychopharmacology","title":"Living Legends in Psychopharmacology: From Evidence Base to Advances in Treatment 2023","description":"\u003cdiv id=\"ucOverview_pnlOverview\"\u003e\n\u003cdiv class=\"prod-format\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003ch4\u003e\u003cem\u003eLiving Legends in Psychopharmacology: From Evidence Base to Advances in Treatment 2023\u003c\/em\u003e\u003c\/h4\u003e\n\u003cem\u003eLiving Legends in Psychopharmacology: From Evidence Base to Advances in Treatment\u003c\/em\u003e centers on the treatment of usual psychiatric patients with emphasis on the difficult to treat or treatment-resistant. Continuing medical education lectures will enhance your ability to choose treatments as you gain an understanding of the interface between psychiatric, neurological, and medical illness.\u003cbr\u003e\u003cbr\u003eLegendary faculty review new antipsychotic medications and treatment augmentation, potential new uses for mood stabilizers, the neurobiologic mechanisms of depression and the role of inflammation, the importance of a therapeutic alliance when prescribing psychotropic medications, and more. With this online CME program, you’ll explore current evidence-based and emerging treatments for:\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eSchizophrenia and bipolar disorder\u003c\/li\u003e\n\u003cli\u003eBipolar and treatment-resistant depression\u003c\/li\u003e\n\u003cli\u003eTMS and ECT\u003c\/li\u003e\n\u003cli\u003eAnxiety spectrum and sleep disorders\u003c\/li\u003e\n\u003cli\u003ePTSD\u003c\/li\u003e\n\u003cli\u003eAlcohol and substance abuse disorders\u003c\/li\u003e\n\u003cli\u003eWomen’s mental health issues\u003c\/li\u003e\n\u003cli\u003eChild, adolescent, and geriatric psychopharmacology\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eLearning Objectives\u003c\/h3\u003e\n\u003cem\u003eAt the completion of this course, you should be able to:\u003c\/em\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eDescribe lessons learned from genomic sequencing of patients with psychiatric illnesses\u003c\/li\u003e\n\u003cli\u003eIdentify unsolved problems regarding the pharmacologic treatment of schizophrenia and learning more effective treatments\u003c\/li\u003e\n\u003cli\u003eDescribe emerging theories and treatments of bipolar disorder, difficult-to-treat depression, bipolar depression, and anxiety disorder\u003c\/li\u003e\n\u003cli\u003eOutline the perils and possibilities of psychedelics and ketamine\u003c\/li\u003e\n\u003cli\u003eRecognize when to utilize ECT and TMS for treatment-resistant depression\u003c\/li\u003e\n\u003cli\u003eIllustrate emerging treatments for PTSD\u003c\/li\u003e\n\u003cli\u003eReview sleep disorders commonly comorbid with psychiatric illness, and appropriate use of medications and treatment\u003c\/li\u003e\n\u003cli\u003eReview interface of medicine and psychiatry with a focus on cancer, cardiovascular disease\u003c\/li\u003e\n\u003cli\u003eReview the interface of neurology and psychiatry with an emphasis on functional neurological disease, hysteria, movement disorders, pain, OCD and others\u003c\/li\u003e\n\u003cli\u003eSummarize the use of genetic tests, serum level measurements, and drug combinations in treatment-resistant depression\u003c\/li\u003e\n\u003cli\u003eIdentify the current role of pharmacotherapy in the treatment of substance use disorders including alcohol, opioids, and cannabis\u003c\/li\u003e\n\u003cli\u003eReview the role of pharmacotherapy in the treatment of psychiatric disorders throughout women’s reproductive lifespan, with a focus on the premenstrual, prenatal, postpartum, and perimenopausal periods\u003c\/li\u003e\n\u003cli\u003eExamine the latest advances and problems associated with treatment approaches in the child, adolescent, and geriatric populations\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch4\u003eTOPICS \/ SPEAKERS\u003c\/h4\u003e\n\u003cdiv class=\"product-tab-content\"\u003e\n\u003cdiv id=\"tab-speaker\"\u003e\n\u003cul\u003e\n\u003cli\u003eLessons Learned from the DNA of Patients with Psychiatric Disorders – \u003cem\u003eDaniel Weinberger, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eNeurology and Psychiatry Interface – \u003cem\u003eMartin Samuels, MD, DSc (hon)\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eThe Interface of Medical and Psychiatric Disorders – Focus on Cancer and Heart Disease – \u003cem\u003eCharles Nemeroff, MD, PhD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eTackling Unsolved Problems in the Pharmacological Treatment of Schizophrenia – Cognitive Impairment, Negative Symptoms, and Partial Treatment Response – \u003cem\u003ePhilip Harvey, PhD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003ePanel Discussion – \u003cem\u003ePhilip Harvey, PhD, Charles Nemeroff, MD, PhD, Martin Samuels, MD, DSc (hon), and Daniel Weinberger, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003ePharmacological Treatment of Bipolar Disorder – \u003cem\u003eRoss Baldessarini, MD, DSc (hon)\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eAnxiety – Treat the Symptom or Treat the Disorder When First Line Therapies Fail – \u003cem\u003eStephen Stahl, MD, PhD, DSc (hon)\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eNeurobiology and Treatment of Post-traumatic Stress Disorder – \u003cem\u003eCharles Nemeroff, MD, PhD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003ePanel Discussion – \u003cem\u003eRoss Baldessarini, MD, DSc (hon), Charles Nemeroff, MD, PhD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003ePsychopharmacologic Treatment of Sleep Disorders – \u003cem\u003eSogol Javaheri, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eTreatment Resistant Depression – \u003cem\u003eStephen Stahl, MD, PhD, DSc (hon)\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003ePsychedelics and Potential Drugs of Abuse as Antidepressants – \u003cem\u003eAlan Schatzberg, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003ePharmacotherapy of Substance Use Disorders – \u003cem\u003eRoger Weiss, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003ePanel Discussion – \u003cem\u003eBarbara Coffey, MD, MS, Sogol Javaheri, MD, Alan Schatzberg, MD, Stephen Stahl, MD, PhD, DSc (hon), and Roger Weiss, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eChild and Adolescent Psychopharmacology – Current Treatment for Best Practices – \u003cem\u003eBarbara Coffey, MD, MS\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003ePsychopharmacology Across the Reproductive Lifespan – From Menarche to Menopause – \u003cem\u003eAriadna Forray, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eGeriatric Psychopharmacology – \u003cem\u003eElizabeth Crocco, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003ePanel Discussion – \u003cem\u003eBarbara Coffey, MD, MS, Elizabeth Crocco, MD, and Ariadna Forray, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cstrong\u003eDate of Original Release:\u003c\/strong\u003e June 1, 2023\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"meducours","offers":[{"title":"Default Title","offer_id":42954397319266,"sku":"MED-AMB02647","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/Living-Legends-in-Psychopharmacology-From-Evidence-Base-to-Advances-in-Treatment-2023-CME-VIDEOS.jpg?v=1779375368","url":"https:\/\/meducourse.com\/products\/living-legends-in-psychopharmacology","provider":"Meducourse","version":"1.0","type":"link"}